1
Enquiry period
with 02.11.2022 14:32
to 07.11.2022 11:00
2
Bidding period
with 07.11.2022 11:00
to 11.11.2022 11:00
3
Auction
14.11.2022 14:00
4
Evaluation

5
Contract

Status Evaluation
Estimated value without VAT 114 010,08 MDL
Period of clarifications: 2 Nov 2022, 14:32 - 7 Nov 2022, 11:00
Submission of proposals: 7 Nov 2022, 11:00 - 11 Nov 2022, 11:00

Supplier technical support:

(+373) 79999801

“Achiziționarea medicamentelor necesare pentru realizarea Programului Național de Combatere a Hepatitelor virale B, C și D, pentru anul 2023, repetat”

Information about customer
Fiscal code/IDNO
Address
MD-2009, MOLDOVA, mun.Chişinău, locality, MD-2009, Republica Moldova, Chişinău str. Cosmescu 3
Web site
---
The contact person
Full name
Macari Doina
Contact phone
+37322222490
Purchase data
Date created
2 Nov 2022, 14:09
Date modified
2 Nov 2022, 14:32
Achizitii.md ID
21066596
CPV
33600000-6 - Produse farmaceutice
Type of procedure
Request price offers (goods)
Award criteria
The lowest price
Funding sources
List of lots
Lot nr. 1 - Entecavirum 1 mg
Budget: 53157.6 MDL
Active
Purchase has not taken place
Documents of the procurement procedure
DUAE Model
Bidding Documents
DUAE Model
2.11.22 14:32
Scrisoare de garantie bancara_Model
Bidding Documents
Scrisoare de garantie bancara_Model
2.11.22 14:32
Propunerea financiară
Technical Specifications
Propunerea financiară
2.11.22 14:32
contract model PN
Bidding Documents
contract model PN
2.11.22 14:32
Documentatia standard.signed
Bidding Documents
Documentatia standard
2.11.22 14:32
Anunt de participare.signed
Bidding Documents
Anunt de participare.
2.11.22 14:32
Propunerea tehnică
Technical Specifications
Propunerea tehnică
2.11.22 14:32
Declaratie privind valabilitatea ofertei_Model
Bidding Documents
Declaratie privind valabilitatea ofertei_Model
2.11.22 14:32
Cerere de participare_Model
Bidding Documents
Cerere de participare_Model
2.11.22 14:32
Declaratie beneficiari efectivi_Model
Bidding Documents
Declaratie beneficiari efectivi_Model
2.11.22 14:32
Only authorized platform users may ask questions during the clarification period.